Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
98.82
-0.13 (-0.13%)
At close: Jan 31, 2025, 4:01 PM
99.14
+0.32 (0.32%)
After-hours: Jan 31, 2025, 7:55 PM EST
Merck & Co. Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Merck & Co. stock have an average target of 124.64, with a low estimate of 104 and a high estimate of 155. The average target predicts an increase of 26.13% from the current stock price of 98.82.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Merck & Co. stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 6 | 7 | 6 |
| Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Hold | 2 | 2 | 2 | 3 | 4 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 12 | 12 | 13 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $123 → $113 | Hold | Maintains | $123 → $113 | +14.35% | Jan 21, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $136 → $119 | Buy | Maintains | $136 → $119 | +20.42% | Jan 13, 2025 |
| UBS | UBS | Strong Buy Maintains $125 → $120 | Strong Buy | Maintains | $125 → $120 | +21.43% | Jan 8, 2025 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $130 → $110 | Strong Buy → Hold | Downgrades | $130 → $110 | +11.31% | Jan 8, 2025 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $136 → $105 | Buy → Hold | Downgrades | $136 → $105 | +6.25% | Dec 20, 2024 |
Financial Forecast
Revenue This Year
64.63B
from 60.12B
Increased by 7.50%
Revenue Next Year
68.00B
from 64.63B
Increased by 5.23%
EPS This Year
7.60
from 0.14
Increased by 5,329.95%
EPS Next Year
8.94
from 7.60
Increased by 17.58%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 67.6B | 74.6B | 80.5B | |||
| Avg | 64.6B | 68.0B | 72.3B | |||
| Low | 61.9B | 63.9B | 67.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 12.4% | 15.4% | 18.4% | |||
| Avg | 7.5% | 5.2% | 6.3% | |||
| Low | 2.9% | -1.1% | -1.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 7.93 | 9.78 | 12.08 | |||
| Avg | 7.60 | 8.94 | 10.44 | |||
| Low | 7.31 | 7.75 | 9.31 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 5,562.5% | 28.6% | 35.1% | |||
| Avg | 5,330.0% | 17.6% | 16.7% | |||
| Low | 5,122.0% | 2.0% | 4.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.